Gene · 58484
Papers3,844
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,844
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long noncoding RNA CLAN promotes lymphangiogenesis in the colorectal carcinoma. | Virchows Arch | 2022 | 36301367 | PubTator, text mining | PubMed |
| Promiscuous Inflammasomes: The False Dichotomy of RNA/DNA Virus-Induced Inflammasome Activation and Pyroptosis. | Viruses | 2022 | 36298668 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Inflammasome in Ischemic Stroke Pathogenesis. | Pharmaceuticals (Basel) | 2022 | 36297283 | PubTator, text mining | PubMed |
| Pesticides and Their Impairing Effects on Epithelial Barrier Integrity, Dysbiosis, Disruption of the AhR Signaling Pathway and Development of Immune-Mediated Inflammatory Diseases. | Int J Mol Sci | 2022 | 36293259 | PubTator, text mining | PubMed |
| Clostridioides difficile Flagellin Activates the Intracellular NLRC4 Inflammasome. | Int J Mol Sci | 2022 | 36293218 | PubTator, text mining | PubMed |
| NLRP1 in Cutaneous SCCs: An Example of the Complex Roles of Inflammasomes in Cancer Development. | Int J Mol Sci | 2022 | 36293159 | PubTator, text mining | PubMed |
| Interactions between the NLRP3-Dependent IL-1β and the Type I Interferon Pathways in Human Plasmacytoid Dendritic Cells. | Int J Mol Sci | 2022 | 36293012 | PubTator, text mining | PubMed |
| The Inflammasomes Adaptor Protein PYCARD Is a Potential Pyroptosis Biomarker Related to Immune Response and Prognosis in Clear Cell Renal Cell Carcinoma. | Cancers (Basel) | 2022 | 36291776 | PubTator, text mining | PubMed |
| Therapeutic Advances of Rare ALK Fusions in Non-Small Cell Lung Cancer. | Curr Oncol | 2022 | 36290895 | PubTator, text mining | PubMed |
| Maltol, a Natural Flavor Enhancer, Inhibits NLRP3 and Non-Canonical Inflammasome Activation. | Antioxidants (Basel) | 2022 | 36290645 | PubTator, text mining | PubMed |
| Subtype Classification, Immune Infiltration, and Prognosis Analysis of Lung Adenocarcinoma Based on Pyroptosis-Related Genes. | Biomed Res Int | 2022 | 36277882 | PubTator, text mining | PubMed |
| Gastric alarmin release: A warning signal in the development of gastric mucosal diseases. | Front Immunol | 2022 | 36275647 | PubTator, text mining | PubMed |
| NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies. | Front Immunol | 2022 | 36275641 | PubTator, text mining | PubMed |
| Integrative Bioinformatics Analysis Revealed Mitochondrial Dysfunction-Related Genes Underlying Intervertebral Disc Degeneration. | Oxid Med Cell Longev | 2022 | 36267810 | PubTator, text mining | PubMed |
| Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19. | Int J Biol Sci | 2022 | 36263178 | PubTator, text mining | PubMed |
| NOD1 and NOD2 Are Potential Therapeutic Targets for Cancer Immunotherapy. | Comput Intell Neurosci | 2022 | 36262606 | PubTator, text mining | PubMed |
| A novel pyroptosis-regulated gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma. | Front Mol Biosci | 2022 | 36262473 | PubTator, text mining | PubMed |
| The Role of Nutrition on Meta-inflammation: Insights and Potential Targets in Communicable and Chronic Disease Management. | Curr Obes Rep | 2022 | 36258149 | PubTator, text mining | PubMed |
| IKKβ binds NLRP3 providing a shortcut to inflammasome activation for rapid immune responses. | Signal Transduct Target Ther | 2022 | 36257930 | PubTator, text mining | PubMed |
| Identification of pyroptosis-related gene signature for predicting prognosis of patients with pancreatic cancer using bioinformatics. | Medicine (Baltimore) | 2022 | 36253973 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58484/papers?page=44